These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9747820)

  • 41. Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
    Chakravarthy A; Abrams RA; Yeo CJ; Korman LT; Donehower RC; Hruban RH; Zahurek ML; Grochow LB; O'Reilly S; Hurwitz H; Jaffee EM; Lillemoe KD; Cameron JL
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1089-96. PubMed ID: 11072167
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of gemcitabine chemotherapy and 3-dimensional conformal radiation therapy/5-fluorouracil on quality of life of patients managed for pancreatic cancer.
    Short M; Goldstein D; Halkett G; Reece W; Borg M; Zissiadis Y; Kneebone A; Spry N
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):157-62. PubMed ID: 22543205
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Concurrent radiotherapy and gemcitabine for unresectable pancreatic adenocarcinoma: impact of adjuvant chemotherapy on survival.
    Ogawa K; Ito Y; Hirokawa N; Shibuya K; Kokubo M; Ogo E; Shibuya H; Saito T; Onishi H; Karasawa K; Nemoto K; Nishimura Y;
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):559-65. PubMed ID: 22019243
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combining gemcitabine with radiation in pancreatic cancer: understanding important variables influencing the therapeutic index.
    Crane CH; Wolff RA; Abbruzzese JL; Evans DB; Milas L; Mason K; Charnsangavej C; Pisters PW; Lee JE; Lenzi R; Lahoti S; Vauthey JN; Janjan NA
    Semin Oncol; 2001 Jun; 28(3 Suppl 10):25-33. PubMed ID: 11510031
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Curative radiation therapy for pancreatic malignancies.
    Cooke EW; Hazard L
    Surg Clin North Am; 2010 Apr; 90(2):341-54. PubMed ID: 20362790
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gemcitabine Adjuvant Therapy for Resected Pancreatic Cancer: A Meta-analysis.
    Yu Z; Zhong W; Tan ZM; Wang LY; Yuan YH
    Am J Clin Oncol; 2015 Jun; 38(3):322-5. PubMed ID: 23934134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel approaches to postoperative chemoradiation therapy in pancreatic cancer.
    Picozzi VJ
    J Gastrointest Surg; 2001; 5(1):8-9. PubMed ID: 11370619
    [No Abstract]   [Full Text] [Related]  

  • 48. [Concurrent chemoradiation therapy with gemcitabine for advanced or relapsed pancreatic tumors].
    Ioka T; Nakaizumi A; Tanaka S; Yamazaki H; Nishiyama K
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():248-53. PubMed ID: 16457260
    [No Abstract]   [Full Text] [Related]  

  • 49. [Adjuvant treatment of pancreatic cancer].
    Oettle H
    Zentralbl Chir; 2003 May; 128(5):411-8. PubMed ID: 12813641
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Adjuvant and additive therapy for cancer of the pancreas].
    Neoptolemos JP; Raraty MG; Ghaneh P; Hickey H; Stocken DD; Dunn JA; Friess H; Büchler MW
    Chirurg; 2003 Mar; 74(3):191-201. PubMed ID: 12647075
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer.
    McGinn CJ; Zalupski MM; Shureiqi I; Robertson JM; Eckhauser FE; Smith DC; Brown D; Hejna G; Strawderman M; Normolle D; Lawrence TS
    J Clin Oncol; 2001 Nov; 19(22):4202-8. PubMed ID: 11709563
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adjuvant therapy for pancreatic cancer: current status.
    Regine WF; John WJ; Mohiuddin M
    Front Biosci; 1998 Nov; 3():E186-92. PubMed ID: 9820740
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of locally advanced adenocarcinoma of the pancreas.
    Ryan DP; Willett CG
    Hematol Oncol Clin North Am; 2002 Feb; 16(1):95-103. PubMed ID: 12063831
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New developments in chemotherapy for patients with advanced pancreatic cancer.
    Rothenberg ML
    Oncology (Williston Park); 1996 Sep; 10(9 Suppl):18-22. PubMed ID: 8884803
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial.
    Oettle H; Neuhaus P; Hochhaus A; Hartmann JT; Gellert K; Ridwelski K; Niedergethmann M; Zülke C; Fahlke J; Arning MB; Sinn M; Hinke A; Riess H
    JAMA; 2013 Oct; 310(14):1473-81. PubMed ID: 24104372
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
    Al-Sukhun S; Zalupski MM; Ben-Josef E; Vaitkevicius VK; Philip PA; Soulen R; Weaver D; Adsay V; Heilbrun LK; Levin K; Forman JD; Shields AF
    Am J Clin Oncol; 2003 Dec; 26(6):543-9. PubMed ID: 14663369
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neoadjuvant chemoradiation for non-metastatic pancreatic cancer increases margin-negative and node-negative rates at resection.
    Berriochoa CA; Abdel-Wahab M; Leyrer CM; Khorana A; Matthew Walsh R; Kumar AMS
    J Dig Dis; 2017 Nov; 18(11):642-649. PubMed ID: 29055078
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary Carcinoma.
    Ecker BL; Vollmer CM; Behrman SW; Allegrini V; Aversa J; Ball CG; Barrows CE; Berger AC; Cagigas MN; Christein JD; Dixon E; Fisher WE; Freedman-Weiss M; Guzman-Pruneda F; Hollis RH; House MG; Kent TS; Kowalsky SJ; Malleo G; Salem RR; Salvia R; Schmidt CR; Seykora TF; Zheng R; Zureikat AH; Dickson PV
    JAMA Surg; 2019 Aug; 154(8):706-714. PubMed ID: 31141112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term results of full-dose gemcitabine with radiation therapy compared to 5-fluorouracil with radiation therapy for locally advanced pancreas cancer.
    Huang J; Robertson JM; Margolis J; Balaraman S; Gustafson G; Khilanani P; Nadeau L; Jury R; McIntosh B
    Radiother Oncol; 2011 May; 99(2):114-9. PubMed ID: 21621866
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Chemotherapy, combined radiochemotherapy and new therapeutic approaches in adenocarcinoma of the pancreas].
    André T; Balosso J
    J Chir (Paris); 1999 Dec; 136(6):309-17. PubMed ID: 10675820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.